Literature DB >> 16411662

Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal.

Jonathan A Doorn1, Thomas D Hurley, Dennis R Petersen.   

Abstract

Previous studies found the lipid peroxidation product 4-hydroxynon-2-enal (4HNE) to be both a substrate and an inhibitor of mitochondrial aldehyde dehydrogenase (ALDH2). Inhibition of the enzyme by 4HNE was demonstrated kinetically to be reversible at low micromolar aldehyde but may involve covalent modification at higher concentrations. Structurally analogous to 4HNE is the lipid peroxidation product 4-oxonon-2-enal (4ONE), which is more reactive than 4HNE toward protein nucleophiles. The goal of this work was to determine whether 4ONE is a substrate or inhibitor of human ALDH2 (hALDH2) and elucidate the mechanism of enzyme inhibition by 4HNE and 4ONE. Both 4ONE and its glutathione conjugate were found to be substrates for the enzyme in the presence of NAD. At low concentrations of 4ONE (< or = 10 microM), hALDH2 catalyzed the oxidation of 4ONE to 4-oxonon-2-enoic acid (4ONEA) with a maximal yield of 5.2 mol 4ONEA produced per mol of enzyme (monomer). However, subsequent analysis of hALDH2 activity toward propionaldehyde revealed that both 4ONE and the oxidation product, 4ONEA, were potent, irreversible inhibitors of the enzyme. In contrast, inhibition of hALDH2 by a high concentration of 4HNE (i.e., 50 microM) was primarily reversible. The reactivity of 4ONEA toward glutathione was measured and found to be comparable to that of 4HNE, indicating that the 4ONE-oxidation product is a reactive electrophile. hALDH2/NAD was incubated with 4HNE, 4ONE, and 4ONEA, and mass spectral analysis of tryptic peptides revealed covalent modification of an hALDH2 active site peptide by both 4ONE and 4ONEA. These data demonstrate that hALDH2 catalyzes the oxidation of 4ONE to 4ONEA; however, the product 4ONEA is a reactive electrophile. Furthermore, both 4ONE and 4ONEA are potent, irreversible inhibitors of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16411662     DOI: 10.1021/tx0501839

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  57 in total

Review 1.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  Inactivation of cytosolic aldehyde dehydrogenase via S-nitrosylation in ethanol-exposed rat liver.

Authors:  Kwan-Hoon Moon; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  FEBS Lett       Date:  2007-07-25       Impact factor: 4.124

3.  Formation of 4-hydroxynonenal from cardiolipin oxidation: Intramolecular peroxyl radical addition and decomposition.

Authors:  Wei Liu; Ned A Porter; Claus Schneider; Alan R Brash; Huiyong Yin
Journal:  Free Radic Biol Med       Date:  2010-11-01       Impact factor: 7.376

4.  SIRT3 deacetylase: the Jekyll and Hyde sirtuin.

Authors:  Dafne M Silberman; Raul Mostoslavsky
Journal:  EMBO Rep       Date:  2011-07-08       Impact factor: 8.807

5.  SIRT3-dependent deacetylation exacerbates acetaminophen hepatotoxicity.

Authors:  Zhongping Lu; Mohammed Bourdi; Jian H Li; Angel M Aponte; Yong Chen; David B Lombard; Marjan Gucek; Lance R Pohl; Michael N Sack
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

6.  Catalytic contribution of threonine 244 in human ALDH2.

Authors:  Lilian González-Segura; K-K Ho; Samantha Perez-Miller; Henry Weiner; Thomas D Hurley
Journal:  Chem Biol Interact       Date:  2013-01-04       Impact factor: 5.192

7.  LC-MS/MS quantitation of mercapturic acid conjugates of lipid peroxidation products as markers of oxidative stress.

Authors:  Heather C Kuiper; Jan F Stevens
Journal:  Curr Protoc Toxicol       Date:  2011-02-01

Review 8.  Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

Authors:  Grant R Budas; Marie-Hélène Disatnik; Daria Mochly-Rosen
Journal:  Trends Cardiovasc Med       Date:  2009-07       Impact factor: 6.677

9.  Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs.

Authors:  Felicitas S Boretti; Paul W Buehler; Felice D'Agnillo; Katharina Kluge; Tony Glaus; Omer I Butt; Yiping Jia; Jeroen Goede; Claudia P Pereira; Marco Maggiorini; Gabriele Schoedon; Abdu I Alayash; Dominik J Schaer
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

10.  Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart.

Authors:  Che-Hong Chen; Grant R Budas; Eric N Churchill; Marie-Hélène Disatnik; Thomas D Hurley; Daria Mochly-Rosen
Journal:  Science       Date:  2008-09-12       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.